Hospital/Health-System Pharmacy
Long-term data reinforce safety profile of dabigatran
JULY 15, 2013
JULY 15, 2013
By: TRACEY WALKER
Results from the RELY-ABLE trial, the RE-LY extension study, support the long-term safety profile of dabigatran etexilate mesylate (Pradaxa, Boehringer Ingelheim Pharmaceuticals) 150 mg twice daily in patients with nonvalvular atrial fibrillation (NVAF), according to a study published in Circulation in mid-June.Tennessee pharmacy board strengthens compounding rules
JULY 15, 2013Less than a month after FDA warned of an outbreak following steroid injections from a compounding pharmacy there, the Tennessee Board of Pharmacy (TBOP) strengthened its oversight of compounding pharmacies.
JULY 15, 2013Less than a month after FDA warned of an outbreak following steroid injections from a compounding pharmacy there, the Tennessee Board of Pharmacy (TBOP) strengthened its oversight of compounding pharmacies.
Pharmacology and therapeutics of pain medications: Part 2
JUNE 10, 2013New CPE Series: June activity available now
JUNE 10, 2013New CPE Series: June activity available now
USPSTF advises against vitamin D, calcium to prevent fractures in healthy adults
MAY 21, 2013After its recent review, the U.S. Preventive Services Task Force (USPSTF) could not recommend vitamin D and calcium supplementation for the primary prevention of fractures in healthy adults.
MAY 21, 2013After its recent review, the U.S. Preventive Services Task Force (USPSTF) could not recommend vitamin D and calcium supplementation for the primary prevention of fractures in healthy adults.
Pharmacist-driven MTM could save ACOs a bundle
MAY 15, 2013Pharmacists are becoming consultants, medication managers, and more in the coordinated care environment of ACOs
MAY 15, 2013Pharmacists are becoming consultants, medication managers, and more in the coordinated care environment of ACOs
Compounding after the meningitis tragedy: NCPA responds
MAY 15, 2013NCPA is working with healthcare leaders in Congress to ensure development of appropriate measures
MAY 15, 2013NCPA is working with healthcare leaders in Congress to ensure development of appropriate measures
Managed Medicaid captures almost half of fee-for-service Rxs, shifts patient care
MAY 15, 2013IMS study analyzes the shift from fee-for-service in four states through changes in prescriptions for antipsychotic drugs, diabetes therapies, and respiratory medications
MAY 15, 2013IMS study analyzes the shift from fee-for-service in four states through changes in prescriptions for antipsychotic drugs, diabetes therapies, and respiratory medications
